Cargando…
Halting targeted and collateral damage to red blood cells by the complement system
The complement system is an important defense mechanism against pathogens; however, in certain pathologies, the system also attacks human cells, such as red blood cells (RBCs). In paroxysmal nocturnal hemoglobinuria (PNH), RBCs lack certain complement regulators which sensitize them to complement-me...
Autores principales: | Jalink, M., de Boer, E. C. W., Evers, D., Havinga, M. Q., Vos, J. M. I., Zeerleder, S., de Haas, M., Jongerius, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243056/ https://www.ncbi.nlm.nih.gov/pubmed/34191092 http://dx.doi.org/10.1007/s00281-021-00859-8 |
Ejemplares similares
-
P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL.
por: de Boer, E. C. W., et al.
Publicado: (2022) -
C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia
por: de Boer, Esther C. W., et al.
Publicado: (2023) -
Immune Activation and Collateral Damage in AIDS Pathogenesis
por: Miedema, Frank, et al.
Publicado: (2013) -
Putting a Halt to HALT: Does Anticoagulation Matter?
por: DeAnda, Abe, et al.
Publicado: (2022) -
Halting 'research waste'
por: Shamsoddin, E., et al.
Publicado: (2021)